Guest blog written by antibodies-online.com The first occurrence of human infections of the novel Coronavirus (COVID-19) was recognized in Wuhan, China. Due to…

Brian Dalby, PhD, Senior Director/Research Concierge at Scientist.com, discusses the biological makeup of Coronavirus SARS-CoV-2. Though much of the world is hearing about…

The direct and indirect impact of sourcing human biological samples present serious risks for the scientific research community. Through Compli™ -a governance process that provides standardization, transparency and ensures ethical sourcing through one single service- researchers can now mitigate risk and reduce overhead while implementing a formal compliance process.

Drug discovery, ever a challenge, can be likened to a tall structure. The upper stories rely on the stability of the floors below…

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work — for…